Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 11/2008

Open Access 01-11-2008 | Brief Research Articles

Patients’ perception of cancer-related fatigue: results of a survey to assess the impact on their everyday life

Authors: Nieves Díaz, Salvador Menjón, Christian Rolfo, Pilar García-Alonso, Joan Carulla, Ana Magro, José Miramón, César A. Rodríguez, Rous de Castellar, José A. Gasquet

Published in: Clinical and Translational Oncology | Issue 11/2008

Login to get access
Metadata
Title
Patients’ perception of cancer-related fatigue: results of a survey to assess the impact on their everyday life
Authors
Nieves Díaz
Salvador Menjón
Christian Rolfo
Pilar García-Alonso
Joan Carulla
Ana Magro
José Miramón
César A. Rodríguez
Rous de Castellar
José A. Gasquet
Publication date
01-11-2008
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 11/2008
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-008-0282-x

Other articles of this Issue 11/2008

Clinical and Translational Oncology 11/2008 Go to the issue

Case Reports

Granulocytic sarcoma of the right humerus in a non-leukaemia patient

Research Articles

Impact of mammography screening programme in the breast cancer population of the Region of Valencia (Spain)

Educational Series

New technologies in cancer and their assessment. The clinical surgeon’s point of view

Editorial

FESEO and Clinical & Translational Oncology: a brief historical perspective

Erratum

Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer

Educational Series

Langerhans cell histiocytosis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits